The characterization and impact of microparticles on haemostasis within fresh-frozen plasma

A S Lawrie1, P Harrison, R A Cardigan

  • 1Haemostasis Research Unit, Department of Haematology, University College London, London, UK. andrew.lawrie@ucl.ac.uk

Vox Sanguinis
|January 6, 2009
PubMed
Abstract

Insights

Microparticles (MPs) in fresh-frozen plasma significantly influence clot formation. Removing MPs via filtration reduced thrombin generation and slowed clot formation, suggesting MPs contribute to clotting in FFP.

Area of Science:

  • Hematology
  • Biochemistry
  • Biophysics

Background:

  • Clot formation in fresh-frozen plasma (FFP) is influenced by microparticles (MPs).
  • Previous studies indicated MP influence on FFP clotting.
  • This study further characterized the cellular source, properties, and impact of MPs on FFP clot formation.

Purpose of the Study:

  • To characterize the cellular source and properties of MPs in FFP.
  • To investigate the influence of MPs on clot formation dynamics in FFP.
  • To assess the effect of MP removal on hemostatic parameters in FFP.

Main Methods:

  • FFP was prepared from whole blood held overnight at 4°C.
  • A 0.2 µm filtration device was used to remove cellular MPs.
  • Thrombin generation test (TGT), Thrombelastography (TEG®), and assays for clotting factors (PT, aPTT, Fg, FVIII, VWF:Ag) and inhibitors (AT-III, PC) were performed.
  • MPs were quantified using a functional assay and flow cytometry.

Main Results:

  • Filtration significantly reduced MP levels (pre- 5.11 vs. post- 4.43 nmol/l PS eq., P < 0.0001).
  • Red blood cells were the primary source of MPs (~87% annexin V positive), with 94% removed by filtration.
  • MP removal minimally affected clotting factors but significantly reduced TGT (endogenous thrombin potential: 1722 vs. 990 nM, P < 0.0001; peak thrombin: 91 vs. 44 nM, P < 0.0001) and altered TEG® parameters, indicating slower clot initiation and reduced formation rate.

Conclusions:

  • MPs are a significant contributor to clot formation in FFP.
  • Red blood cell-derived MPs play a key role in enhancing thrombin generation.
  • Filtration of MPs alters FFP's hemostatic potential, impacting clot kinetics.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...